- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Real-life cost-effectiveness of benralizumab in patients with severe asthma ; volume:22 ; number:1 ; day:27 ; month:5 ; year:2021 ; pages:1-14 ; date:12.2021
Respiratory research ; 22, Heft 1 (27.5.2021), 1-14, 12.2021
- Creator
-
Padilla-Galo, A.
García-Ruiz, A. J.
Levy Abitbol, R. Ch
Olveira, C.
Rivas-Ruiz, F.
García-Agua Soler, N.
Pérez Morales, M.
Valencia Azcona, B.
Tortajada-Goitia, B.
Moya-Carmona, I.
Levy-Naon, A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-021-01758-0
- URN
-
urn:nbn:de:101:1-2021092320024542006243
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Padilla-Galo, A.
- García-Ruiz, A. J.
- Levy Abitbol, R. Ch
- Olveira, C.
- Rivas-Ruiz, F.
- García-Agua Soler, N.
- Pérez Morales, M.
- Valencia Azcona, B.
- Tortajada-Goitia, B.
- Moya-Carmona, I.
- Levy-Naon, A.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness analysis of a state funded programme for control of severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Cost-effectiveness of activated protein C in real-life clinical practice
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Cost-effectiveness analysis of a state funded programme for control of severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Cost-effectiveness of activated protein C in real-life clinical practice
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
Cost-effectiveness analysis of a state funded programme for control of severe asthma
Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
Cost-effectiveness of activated protein C in real-life clinical practice
Advocating an attack against severe malaria: a cost-effectiveness analysis
Cost-utility of tiotropium in patients with severe asthma
Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia